Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Virtual MSL/Sales training programs and events

June 27, 2022 | MSLs, Sales, Sales training, Virtual training programs, learning programs, medical affairs, training 

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Well-designed internal training programs enable Medical Science Liaisons (MSLs), Sales Representatives, and other field staff to better explain, analyze, and discuss the current clinical landscape, available products/devices, new clinical and real-world data, as well as patient lifestyle management strategies. It also improves their overall knowledge of the therapeutic area and improves their ability to clearly and effectively communicate with healthcare providers (HCPs). In turn, this can enable HCPs to make better choices for their patients, theoretically resulting in better treatment outcomes.

In today’s virtual world, online and hybrid training programs and events are becoming commonplace. However, the quality and outcomes vary between programs; that is: if they are even being evaluated. In this top-10 article, we share 10 innovative ways that life science teams can leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events.

Learn more here: https://www.impetusdigital.com/2022/05/09/top-10-msl-sales-training-programs-and-events/

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Virtual MSL/Sales training programs and events

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...

The Future of MedTech: Streamlined Clinical Data Collection & Management

Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!

Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?

With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and...

Engaging Patients “Just-In-Time” with Machine Learning

Omri Shor, Co-founder & CEO of Medisafe, explores how Pharma companies can use digital therapeutics for advancing and supporting the patient journey, how new digital health tools are driving deeper...

Improving Drug Access with Data Analytics

Earlene Biggs, VP of Market Research & Analytics at ICON, explores best practices for life science market research and actionable analytics. She also shares her tips for creating organizational wellbeing...

Innovative Medical Solutions for Postponing and Undoing Age-Related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, discusses a range of interesting topics surrounding innovative interventions and technologies that could not just postpone, but theoretically reverse, age-related...

Top 10 Creative Ways to Engage Your Advisors

At Impetus Digital, we pride ourselves with being the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight-synthesis. Our most popular service is online advisory boards. However, there is a myriad of...

AI in Healthcare: How to Accelerate Change

Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public...